Zee Laboratories supplies medicines to government hospitals and institutions such as AIIMS, as well as to central and state ...
Serán Bioscience, LLC,  in collaboration with leading developer and design-builder Mortenson, hosted a topping-out ceremony ...
Given the complexity of alternative-protein manufacturing, many biotech companies are exploring how to reduce costs with AI technologies, process improvements and novel uses for waste streams from ...
Arsenale Bioyards standardizes biomanufacturing from the industrial side, aiming to make biopharmaceutical manufacturing efficient, scalable, and cost-effective, much as the Bessemer converter did for ...
Under the agreement, Northway Biotech will leverage its expertise in biologics manufacturing to develop and scale the production process for ATL-105 using the Pichia pastoris expression system. “With ...
BioNTech has already been tinkering with its manufacturing processes in the run up to CAR-T BNT211 entering pivotal trials. Now, the German biotech has brought British company Autolus Therapeutics on ...
Residues of pharmaceutical products can enter the environment during the manufacturing process, during usage, and disposal. With the growing trend in sustainable practices, the translation of ...
Trinity Biotech plc, a biotechnology company focusing on human diagnostics and diabetes management, has announced a significant update to its Comprehensive Transformation Plan, which includes ...
VILNIUS, LT / ACCESS Newswire / July 29, 2025 / Diorasis Therapeutics (“DTx”), a preclinical-stage biotechnology company developing gene therapies for ophthalmic diseases, has entered into a strategic ...
Houston-based clinical-stage biotechnology company FibroBiologics Inc. opened a manufacturing laboratory at 9350 Kirby Drive in the Texas Technology Park. It will bring manufacturing operations ...
Antibiotic factories release resistance genes at levels 100x higher than city sewage. Pharmaceutical pollution is fueling ...
Leveraging Northway Biotech's 20+ years of CDMO expertise, Diorasis Therapeutics is advancing DT003, a single-dose AAV gene therapy for glaucoma. As part of the collaboration, Northway Biotech will ...